Stock PHIA PHILIPS NV
Add to a list
To use this feature you must be a member
Log inSign up

Financials Philips NV

Equities

PHIA

NL0000009538

Advanced Medical Equipment & Technology

Market Closed - Euronext Amsterdam
Other stock markets
 11:38:02 2024-04-30 am EDT 		After market 01:33:55 pm
25.25 EUR -1.14% Intraday chart for Philips NV 25.22 -0.14%
04:54pm UBS Upgrades Koninklijke Philips to Neutral From Sell MT
04:00pm PHILIPS : Deutsche Bank upgrades recommendation to 'hold CF

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 38,967 39,817 28,161 12,398 19,314 23,095 - -
Enterprise Value (EV) 1 42,989 43,525 32,837 18,485 25,131 28,012 27,636 26,643
P/E ratio 33.5 x 33.9 x 8.98 x -7.69 x -41.3 x 42.4 x 22.1 x 18.5 x
Yield 1.95% 1.94% 2.59% 6.07% 4.03% 3.47% 3.65% 3.91%
Capitalization / Revenue 2 x 2.04 x 1.64 x 0.7 x 1.06 x 1.23 x 1.17 x 1.12 x
EV / Revenue 2.21 x 2.23 x 1.91 x 1.04 x 1.38 x 1.5 x 1.4 x 1.29 x
EV / EBITDA 11.9 x 11.7 x 11 x 8.02 x 8.83 x 8.97 x 8.05 x 7.27 x
EV / FCF 40.8 x 23.5 x 36.5 x -19.2 x 15.9 x 23.7 x 26 x 16.3 x
FCF Yield 2.45% 4.26% 2.74% -5.2% 6.3% 4.22% 3.85% 6.13%
Price to Book 3.08 x 3.34 x 1.97 x 0.93 x 1.61 x 1.97 x 1.88 x 1.78 x
Nbr of stocks (in thousands) 954,336 950,090 897,866 924,889 915,987 904,257 - -
Reference price 2 40.83 41.91 31.36 13.41 21.08 25.54 25.54 25.54
Announcement Date 1/28/20 1/25/21 1/24/22 1/30/23 1/29/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 19,482 19,535 17,156 17,827 18,169 18,727 19,727 20,673
EBITDA 1 3,615 3,709 2,985 2,305 2,845 3,123 3,435 3,665
EBIT 1 2,563 2,570 2,054 1,318 1,921 2,147 2,240 2,497
Operating Margin 13.16% 13.16% 11.97% 7.39% 10.57% 11.46% 11.35% 12.08%
Earnings before Tax (EBT) 1 1,529 1,490 509 -1,731 -526 581.9 1,590 1,934
Net income 1 1,167 1,187 3,319 -1,608 -466 853 1,163 1,404
Net margin 5.99% 6.08% 19.35% -9.02% -2.56% 4.55% 5.9% 6.79%
EPS 2 1.220 1.235 3.494 -1.742 -0.5100 0.6026 1.155 1.382
Free Cash Flow 1 1,053 1,852 900 -961 1,582 1,181 1,065 1,633
FCF margin 5.4% 9.48% 5.25% -5.39% 8.71% 6.31% 5.4% 7.9%
FCF Conversion (EBITDA) 29.13% 49.93% 30.15% - 55.61% 37.82% 30.99% 44.57%
FCF Conversion (Net income) 90.23% 156.02% 27.12% - - 138.47% 91.53% 116.3%
Dividend per Share 2 0.7975 0.8137 0.8137 0.8137 0.8500 0.8860 0.9326 0.9995
Announcement Date 1/28/20 1/25/21 1/24/22 1/30/23 1/29/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2020 S1 2021 S1 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 S1 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 8,554 8,057 4,156 4,944 3,918 4,177 8,095 4,310 5,422 4,167 4,470 4,471 5,062 4,138 4,550 4,708 5,504 -
EBITDA - - - - - - - - - - - - 896 - - - - -
EBIT 662 - 512 - 243 216 459 209 651 359 453 457 653 - 475 582.6 837.3 -
Operating Margin 7.74% - 12.32% - 6.2% 5.17% 5.67% 4.85% 12.01% 8.62% 10.13% 10.22% 12.9% - 10.44% 12.37% 15.21% -
Earnings before Tax (EBT) - - - - - - - - 7 - - 130 - - - - - -
Net income 1 246 - 2,973 157 -151 -22 -173 -1,330 -106 - 72 88 39 -999 711.7 247.2 217.3 -
Net margin 2.88% - 71.54% 3.18% -3.85% -0.53% -2.14% -30.86% -1.95% - 1.61% 1.97% 0.77% -24.14% 15.64% 5.25% 3.95% -
EPS 2 - - 3.101 0.1723 -0.1627 -0.0191 - -1.436 -0.1149 - 0.0800 0.0900 0.0400 -1.100 0.7874 0.2742 0.2359 -
Dividend per Share 2 - - - 0.8137 - - - - 0.8137 - - - - - - - - -
Announcement Date 7/20/20 7/26/21 10/18/21 1/24/22 4/25/22 7/25/22 7/25/22 10/24/22 1/30/23 4/24/23 7/24/23 10/23/23 1/29/24 4/29/24 - - - -
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 4,022 3,708 4,676 6,087 5,817 4,918 4,542 3,548
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 1.113 x 0.9997 x 1.566 x 2.641 x 2.045 x 1.575 x 1.322 x 0.9682 x
Free Cash Flow 1 1,053 1,852 900 -961 1,582 1,181 1,065 1,633
ROE (net income / shareholders' equity) 14.9% 9.7% 25.3% 6.1% 9.08% 11.4% 13.4% 13.6%
ROA (Net income/ Total Assets) 6.94% 6.63% 5.1% 2.74% 3.82% 1.07% 3.8% 4.78%
Assets 1 16,817 17,906 65,043 -58,658 -12,197 79,409 30,587 29,355
Book Value Per Share 2 13.30 12.50 15.90 14.40 13.10 12.90 13.60 14.30
Cash Flow per Share 2 2.090 2.900 1.710 -0.1900 2.330 1.840 2.300 2.620
Capex 1 978 924 729 788 554 880 928 977
Capex / Sales 5.02% 4.73% 4.25% 4.42% 3.05% 4.7% 4.7% 4.72%
Announcement Date 1/28/20 1/25/21 1/24/22 1/30/23 1/29/24 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Philips NV

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
17
Last Close Price
25.54 EUR
Average target price
23.14 EUR
Spread / Average Target
-9.42%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
PHILIPS NV Stock Philips NV
+19.75% 24.75B
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+7.77% 220B
DANAHER CORPORATION Stock Danaher Corporation
+6.06% 183B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+10.39% 133B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+24.41% 107B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
-0.95% 63.05B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+11.08% 51.74B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
+4.81% 50.47B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-0.94% 40.91B
RESMED, INC. Stock ResMed, Inc.
+23.19% 31.91B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. PHIA Stock
  4. Financials Philips NV